{"url_path":"/sec/cik-0001848861/8-k/2026-05-12/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1848861/0001477932-26-002984-index.html","accession_number":"0001477932-26-002984","cik":"0001848861","ticker":null,"issuer_name":"Healthcare AI Acquisition Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1848861/0001477932-26-002984-index.html","primary_entity_key":"0001848861","primary_entity_name":"Healthcare AI Acquisition Corp."},"word_count":325,"has_tables":true,"body_markdown":"haia_8k.htm\n0001848861false00018488612026-05-062026-05-060001848861haia:ClassAOrdinaryShareAndRedeemableWarrantMember2026-05-062026-05-060001848861haia:ClassAOrdinarySharesMember2026-05-062026-05-060001848861haia:ClassAOrdinaryShareWarrantMember2026-05-062026-05-06iso4217:USDxbrli:sharesiso4217:USDxbrli:shares\n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**Form 8-K**\n\n \n\n**Current Report**\n\n**Pursuant to Section 13 or 15(d) of the**\n\n**Securities Exchange Act of 1934**\n\n \n\n**May 6, 2026**\n\nDate of Report (Date of earliest event reported)\n\n \n\n**HEALTHCARE AI ACQUISITION CORP.**\n\n(Exact Name of Registrant as Specified in its Charter)\n\n \n\n**Cayman Islands**\n\n \n\n**001-41145**\n\n \n\n**98-1585450**\n\n(State or other jurisdiction\n\nof incorporation)\n\n \n\n(Commission\n\nFile Number)\n\n \n\n(I.R.S. Employer\n\nIdentification No.)\n\n \n\n**418 Broadway #6434**\n\n**Albany NY 12207**\n\n(Address of principal executive offices, including zip code)\n\n \n\n**(917) 446-0469**\n\nRegistrant’s telephone number, including area code: \n\n \n\n**Not Applicable**\n\n(Former name or former address, if changed since last report)\n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n☐\n\nWritten communications pursuant to Rule 425 under the Securities Act\n\n \n\n☐\n\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act\n\n \n\n☐\n\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act\n\n \n\n☐\n\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act: None.\n\n \n\nSecurities registered pursuant to Section 12(g) of the Act:\n\n \n\n**Title of each class**\n\n \n\n**Trading Symbol(s)**\n\nUnits, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant\n\n \n\nHAIUF\n\n \n\n \n\n \n\nClass A Ordinary Share, par value $0.0001 per share\n\n \n\nHAIAF\n\n \n\n \n\n \n\nWarrant, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share\n\n \n\nHAIWF\n\n \n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).\n\n \n\nEmerging growth company ☒\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}